International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-6 doi: 10.5281/zenodo.10068222
Original Article
Sculpting Treatment Strategies: The Art of Managing Chronic Osteomyelitis with Culture and Sensitivity
 ,
Published
March 11, 2023
Abstract

Background: Chronic osteomyelitis is a common infection especially in developing country like India. This is very common in younger children and in majority of the time it is due to hematogenous spread of bacteria. Osteomyelitis is still continued as a major problem due to treatment failure and multidrug resistance. This study was conducted to determine the pus culture of chronic osteomyelitis and their susceptibility pattern to various antimicrobial drugs.

Methods: This is prospective study in 63 patients over a period of 8 months. Cases attending orthopaedic department with chronic osteomyelitis were subjected to pus culture and sensitivity testing.

Results: Incidence of osteomyelitis in male is 73.01% and female is 26.98%. Incidence of chronic osteomyelitis following trauma is 61.90%. The most common bone involved was tibia 44.44%. The most commonly isolated organism was staph aureus 55.93 % followed by coagulase negative staph   16.95% and Pseudomonas aeruginosa 11.86 %. Staph aureus showed 100% sensitivity against Vancomycin and Linezolid.

Conclusions: Continued surveillance for incidence of drug resistance among microorganism causing chronic osteomyelitis should be done and also antimicrobial policy should be updated based on sensitivity pattern.

Recommended Articles
Loading Image...
Volume-4, Issue-6
Citations
1731 Views
492 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved